TruthArchive.ai - Related Video Feed

Some antiparasitic drugs like mabendazole and ivermectin have shown effectiveness against certain cancers. Combining these drugs with others has led to the disappearance of solid tumors in some patients. It's not a single drug but a combination approach that yields results.

Fenbendazole is presented as not simply a dog dewormer, but a drug with broad veterinary use and potential human relevance. It binds to tubulin in parasites, preventing movement and glucose use, causing death. It treats nematodes, flukes, and protozoa like Giardia, across species from cattle to bears. It is not widely approved for human use, unlike its cousins mebendazole and albendazole, which are approved for people; fenbendazole is approved for animals. In 2016, Joe Tippins, with small cell lung cancer at MD Anderson, after hospice, tried fenbendazole on advice of a large-animal vet; within three months his scans were clean and remain so. Mechanistically, fenbendazole disrupts microtubules, halting mitosis and triggering apoptosis, arrests at G2, upregulates p53 and p21, and inhibits Hexokinase II, reducing glycolysis. It may enhance immune recognition and revert tumor-associated macrophages from M2, contributing to tumor control.

I found over 100 scientific papers showing Ivermectin's potential against cancer, primarily from preclinical studies. Researchers are puzzled by how this anti-parasitic drug, which has been effective for decades, can also treat cancer. Ivermectin is off patent, meaning there's little financial incentive for big pharma to invest in its research. Notably, Ivermectin can kill cancer stem cells, reverse chemotherapy resistance, and enhance the effectiveness of both chemotherapy and radiation. Patients combining Ivermectin with these treatments have shown remarkable results, including significant tumor reductions. After two years of research, I now treat over 1,000 cancer patients with Ivermectin and other anti-parasitic drugs. The recent mention by Mel Gibson about friends curing stage 4 cancer with these treatments highlights the growing awareness of this approach.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a textile dye but has shown significant benefits for mitochondria. It's surprising to see effective treatments being overlooked, raising questions about the medical industry's priorities. Why are cures that aren't profitable often ignored or demonized? This situation highlights a failure in our medical institutions to promote genuinely effective solutions.

Fenbendazole is an overlooked cancer drug with at least 12 proven anti-cancer mechanisms. It disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability, migration, and invasion, induces apoptosis, autophagy, and necrosis, and inhibits angiogenesis and drug resistance. Mebendazole, a similar drug, is already approved by the FDA and in clinical trials for brain and colon cancers. However, there are no Fenbendazole clinical trials for cancer, likely because it is cheap, safe, and effective. Big pharma may not see a profit margin in it, which raises concerns about their motives. This highlights the issue of a society designed to make people sick, with pharmaceutical companies profiting from remedies.

"We get sick because of three things primarily. We get sick because of electromagnetic radiation, because of poisons that they put into the environment, and because of parasites." "I found about about five or six years ago, underground group of people that were using Fenbendazole in these things for cancer, and it was working." "He had throat cancer." "So his wife searched around the internet and found this story about the Fenbendazole and started treating him using the protocol." "Isn't it interesting that parasitic medication also treats cancer?" "I think it's not that it also treats cancer, it's that cancer is parasites."

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking 8 pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a fabric dye but is now known to have significant effects on mitochondria. It's surprising to discover that many effective treatments are overlooked or demonized, raising questions about the motives behind our medical institutions. Why are these cures not promoted when they are not profitable?

The speaker notes that certain parasite medications show strong potential in targeting glutamine metabolism in cancer. Specifically, the Benzazole class and Fenbendazole are highlighted as medications being explored in this context. The central question addressed is why a parasite medication might be effective against cancer cells. The answer given is that parasites and cancer cells share a common metabolic pathway: glutaminolysis. This pathway involves substrate-level phosphorylation in the mitochondria, and it is the same metabolic process being targeted. The speaker references a recent publication related to this mechanism, described as a paper with Derek’s big paper, indicating that the concept and supporting data have been recently published. The emphasis is on the idea that inhibiting glutaminolysis could disrupt a critical energy and biosynthetic pathway that both parasite-infected cells and cancer cells rely upon, potentially providing a therapeutic avenue. The discussion reinforces that the medications under consideration—Benzazole compounds and Fenbendazole—are being actively developed or tested for their ability to interfere with this shared mitochondrial metabolic route. Additionally, the speaker connects the effectiveness of these parasite drugs to the broader principle that targeting a common metabolic vulnerability in cancer cells may yield translational opportunities from antiparasitic strategies. The overall point is that leveraging parasite medicines, which may disrupt glutaminolysis, could offer a way to impair cancer cell metabolism through mitochondrial substrate-level phosphorylation, a mechanism now supported by recent publication activity. The takeaway is that there is ongoing work to validate the approach of repurposing parasite-targeting drugs to exploit the glutaminolysis pathway in cancer, with empirical support emerging from the referenced Derek-associated publication.

Ivermectin and mebendazole may disrupt cancer cell metabolism and glioma growth. Ivermectin blocks tumor cells from generating energy through oxidative phosphorylation, inhibits cancer stem cells, and disrupts glucose uptake. Mebendazole interferes with microtubule formation in glioma cells, induces apoptosis, and crosses the blood brain barrier. These drugs are backed by emerging science and used in terrain-based cancer protocols. When combined with fasting, oxygen therapy, and targeted nutrition, they may help flip the metabolic switch and support the body's natural healing power. The speaker claims this is how they overcame stage four brain cancer. The speaker is offering their complete healing protocol for free to those who comment "protocol."

Alternative cancer treatments include a ketogenic diet, long-term fasting for autophagy, and repurposed drugs like ivermectin and fenbendazole. Research on dosing protocols is ongoing, along with exploring vitamin C IV infusions. Low dose naltrexone is not yet studied. The speaker shares their research on Substack due to restrictions on oncologists. Translation: Alternative cancer treatments such as ketogenic diet, fasting, and repurposed drugs like ivermectin and fenbendazole are being explored. Research on dosing protocols is ongoing, along with investigating vitamin C IV infusions. Low dose naltrexone has not been studied yet. The speaker shares their research on Substack due to restrictions on oncologists.

I am presenting a case series of three patients whose cancers went into remission after taking the antiparasitic drug fenbendazole, as detailed in a paper published in Clinical Oncology Case Reports. Fenbendazole is a veterinary medicine that interferes with microtubule formation during cell division, which may inhibit cancer cell proliferation. This suggests it could be a safe and effective option for cancer treatment. There is an urgent need for drug regulators to consider repurposing fenbendazole for human use, especially since other safe treatments have been approved quickly. Further research is necessary to establish its role as a chemotherapy option. The paper indicates that these three patients experienced significant improvement in their cancer conditions. For more details, refer to the full paper.

Ivermectin is taken seriously by oncology in the UK and has shown anti-cancer activity, along with other drugs like thalidomide, CBD, and artemisinins. Ivermectin has multiple anti-cancer mechanisms and is given to millions worldwide, reportedly saving two million people a year from blindness. Mebendazole and febendazole, similar anti-parasitics, also have crossover links. Anecdotal evidence suggests these are used when conventional therapies fail. Ivermectin has few side effects at doses several times higher than normal, while mebendazole may cause liver toxicity, so intermittent use is recommended. A concoction of both is used to extend cancer treatment efficacy. Studies are needed to determine if there is real benefit, identify which people respond, determine the best management protocol and dose, and create a database of when ivermectin works. Oncology is using very high doses compared to normal. Intermittent use may be better than constant exposure. Formal studies are needed to determine if intermittent ivermectin at normal doses with mebendazole/febendazole is better than continuous high-dose ivermectin.

Fenbezodizole, a potential miracle drug for cancer, has at least 12 proven anti-cancer mechanisms of action. It is speculated that big pharma fears this drug due to its low cost. There is hope that Flint, who is mentioned in the conversation, will be interested in examining it. The drug disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability and migration, induces autophagy, apoptosis, and necrosis, and inhibits angiogenesis and drug resistance. A similar drug, menbendazole, is already approved by the FDA and in clinical trials for brain and colon cancers. The lack of clinical trials for Fenbezodizole may be due to its low cost and effectiveness. Big pharma's lack of interest in it is seen as preventing people from accessing potentially beneficial treatments. The conversation also touches on the idea that society is designed to make people sick, with big pharma profiting from remedies.

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking eight pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

Speaker 0: I have three friends. All three of them had stage four cancer. All three of them don't have cancer right now at all. And they had some serious stuff going on. And what did they take? Yep. Jesus. They took some what you've heard they've taken. Speaker 1: Ivermectin. Fenbendazole. Fenbendazole. Yeah. Speaker 0: That's it. Speaker 1: Yeah. I'm hearing that a lot. Speaker 0: They drank hydrochloride something or other? There's studies on Speaker 1: that now where people have proven that they've Speaker 0: drinking methylene blue and stuff Speaker 1: like that. Yeah. Methylene blue, which was a fabric dye. Speaker 0: Yeah. Yeah. It was a textile dye, and now they find it has profound effects on your mitochondria. Yep. Yeah. Speaker 0: This stuff works, man. There's a lot of stuff that does work, which is very strange Speaker 1: Mhmm. Because, again, it's profit. When you when you hear about things that are demonized and that that turn out to be effective, you always wonder, well, what is going on here? Mhmm. How is how is our medical institutions how have they failed us so that things that do cure you are not promoted because they're not profitable?

Thirty years, forty years. They'll look back at chemotherapy as a barbaric and kind of caveman like thinking of destroying the entire body to treat a cancer. Know, we gotta get away from this. We gotta move towards targeted approaches and even towards natural compounds, like medicinal mushrooms—cordyceps, turkey tail mushroom—these have shown lots of promise. But also ivermectin and fenbendazole are now gaining national attention as possible cancer treatments, with positive anecdotal reports of remission after taking these products. A recent study—a systematic review of ivermectin in cancer—found not only is it completely safe if people are undergoing conventional treatment, but it does show potent anti-tumor effects in the test tube via 10 mechanisms. And so, we gotta go to natural compounds. Forty years from now, I hope we’re not still administering chemotherapy as the main form of treatment.

Fenbendazole is described as more than just a dog dewormer, comparing that description to saying water is only for lawns. It works on various animals, impacting cestodes, nematodes, flukes, and protozoa like giardia. Fenbendazole isn't approved for human use because research is done on animals, while its cousins, mebendazole and albendazole, are researched on humans. Joe Tippins, diagnosed with small cell lung cancer, was sent home with hospice after chemotherapy led to metastasis. Following a vet's advice, he took fenbendazole, and within three months, his scans were clear. Fenbendazole binds to microtubules, preventing mitosis and causing apoptosis, similar to taxanes and vinca alkaloids. It arrests cells, upregulates tumor suppressor genes like p53 and p21, and is similar to metformin in glucose control. It inhibits hexokinase two, which is upregulated in cancers to increase glucose uptake. It also helps the immune system recognize tumors and reverses tumor-associated macrophages.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like ivermectin, fenbendazole, and methylene blue, which was originally a textile dye but is now found to have significant effects on mitochondria. It's surprising how many effective treatments are overlooked or demonized, often due to profit motives. Many beneficial substances, such as vitamin D, K2, magnesium, zinc, and quercetin, are not promoted because they lack patent protection and cannot be controlled by pharmaceutical companies.

The speaker focuses on treating stage four cancer patients, often with late diagnoses. They use ivermectin combined with fenbendazole or mebendazole, both antiparasitics, even in early-stage breast cancer cases before surgery. The speaker claims that stage four cancers, including pancreatic, ovarian, and melanoma, have responded, with some patients becoming cancer-free. Tumors reportedly shrink significantly within months when patients take ivermectin and mebendazole before surgery. The speaker notes that ivermectin and fenbendazole are inexpensive, off-patent drugs, but customs in British Columbia and Mississauga are allegedly confiscating packages. A published paper supports the use of ivermectin and fenbendazole in cancer treatment. The speaker treated a friend of Mel Gibson, who then shared the story on Joe Rogan's podcast. Ivermectin is described as a chemo and radio sensitizer. The speaker faced backlash from a pancreatic cancer support group for sharing a patient's story. The speaker claims to have patients in hospice who are now cancer-free and one patient who was offered medical assistance in dying but is now cancer-free. The speaker recounts a case where a patient with terminal melanoma and liver failure stabilized and improved with ivermectin and fenbendazole. Oncologists are portrayed as limited to expensive, profitable treatments.

- It acts on these signaling pathways called PAC-one and ACT and MTOR and WNT pathways, these are pathways that are involved in tumor proliferation, tumor growth. - ivermectin inhibits multiple of these pathways that inhibit tumor growth, tumor proliferation, leads to cell cycle arrest, and it also inhibits metastases and the ability of the tumors to create blood vessels for themselves. - Then ivermectin also acts on cancer stem cells. It inhibits cancer stem cells. - They're involved in metastases, and they're involved in cancer recurrence. - cancer stem cells tend to be resistant to chemo. And then your cancer comes roaring back because these cancer stem cells start proliferating again. - So it inhibits cancer stem cells, very important. - Ivermectin also reverses multi drug resistance. So if you develop resistance to certain chemotherapy, Ivermectin will reverse it and Ivermectin acts in combination with chemo or radiation therapy. - Guzzo 2002 safety study: "the conclusion was that ivermectin was generally well tolerated with no indication of CNS toxicity." - up to two milligrams per kilogram per day.

Ivermectin, the controversial anti-parasitic drug, has shown potential in stopping the growth or killing certain cancer cells. Research suggests that it may be effective against various types of cancer, including breast, prostate, stomach, colon, liver, lung, kidney, and leukemia. Ivermectin induces apoptosis, or natural cell death, in cancer cells. It is even being used alongside chemotherapy for breast cancer. However, it is important to consult with your doctor before considering Ivermectin for any purpose. For more information on fighting cancer, you can watch a lecture by Dr. Shintani at ehealthandu.com. This is Dr. Chintani, a board-certified MD and nutritionist trained at Harvard, signing off for your health.

Speaker 0: We also know that certain parasite medications are very effective, can be very effective in targeting glutamine. And Benzol, Fenbendazole, we're working on that right now. Why would a parasite medication be effective in killing cancer? Because the parasite and the cancer cell use a common metabolic pathway, the glutaminolysis pathway, which is a substrate level phosphorylation in the mitochondria that we just published with Derek's big paper.

Fenbendazole, a potential cancer drug, has at least 12 proven anti-cancer mechanisms. It disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability and migration, induces apoptosis and autophagy, inhibits angiogenesis and drug resistance, and sensitizes cells to chemo and radiation therapy. Mebendazole, a similar drug, is already in clinical trials for brain and colon cancers. However, there are no clinical trials for Fenbendazole, possibly because it is cheap, safe, and effective. Big pharma may not see a profit in it. This raises concerns about withholding information and preventing people from using potentially beneficial treatments. The current society seems to promote sickness, allowing big pharma to profit from remedies.

But I think there's you know, what's beautiful now because so many doctors are stepping up and seeing something and talking about something, I'm not saying that's the right thing. 'Is ivermectin improving cancer? Certainly some doctors have seen it.' 'So is that the way we is it improving for everybody? What is it in ivermectin that improves the microbiome of certain people and not in others? What is it in ivermectin that helps certain cancers and not others? Right? So we really need to be better to say, okay, look, I'm courageous enough to add ivermectin to my protocol of the chemo or the bio or the immunotherapy that I'm giving or maybe I don't.' 'And maybe at least I look at the microbiome. I look at the microbiome on what is believed right now, you know, a a good look at it.'